09.18.23
Crown Aesthetics, a division of Crown Laboratories, Inc., has expanded Biojuve into the United Kingdom, Ireland and Germany—the largest aesthetic market in Europe.
Biojuve is a novel skin biome brand that uses a clinically proven, living microbe technology to optimize the overall skin biome and lead to healthier, younger-looking skin.
Developed by Crown's R&D team, led by tissue engineer and geneticist Dr. Thomas M. Hitchcock, Ph.D., chief science officer, Biojuve stands at the forefront of biological advancements, according to the 2023 Happi Top 50 Company. The microbial powerhouses within the patented Xycrobe Technology naturally produce and deliver around the clock Bioessentials such as proteins, polypeptides and antioxidants to optimize skin health and vitality.
"We're thrilled to be able to introduce our latest innovation, Biojuve, to UKI and German markets," said Michael McKenna, executive vice president and general manager of Crown Aesthetics. "The brand has enjoyed tremendous success since it first launched in the US at the beginning of 2023. It quickly gained momentum with several notable dermatologists signing on as early adopters. We're looking forward to the brand's international expansion and to educating consumers worldwide about the importance of maintaining a healthy skin biome with Biojuve."
Biojuve will be available through aesthetic providers throughout the regions. The Biojuve line is slated to further expand to the EU in January 2024.